The Need for Breathing Retraining: the Elephant in the Cardiac Rehabilitation Room
Chronic Heart Failure
About this trial
This is an interventional treatment trial for Chronic Heart Failure focused on measuring chronic heart failure, inspiratory muscle training, cardiac rehabilitation
Eligibility Criteria
Inclusion Criteria:
. chronic heart failure (≥ 1 year) .Respiratory muscle weakness≤ 70% of their predicted MIP.
- Ages ranged from 45-65 years old
- Left ventricle ejection fraction ≤ 40% in NYHA class II and III .In stable condition (No rales on auscultation or tibial edema and with sinus rhythm).
- On standard cardiac medications (diuretics, angiotensin-converting enzyme (ACE) inhibitors, and glycosides)
- Not engaged in any regular physical training program for at least one month before the start of the study.
Exclusion Criteria:
Chronic lung disorders,
- Anemia
- Severe hypoxia
- History of myocardial infarction or pulmonary edema six months before the study
- Severe uncontrolled hypertension, or uncontrolled diabetes mellitus or autonomic disorders
Sites / Locations
- National heart institute
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Cardiac rehabilitation with breathing retraining
cardiac rehabilitation
A cardiac rehabilitation program for 3 days/week (day after day) for 12 weeks(including aerobic, and resisted exercise, with educational sessions, and counseling), with a breathing retraining (using breathing calisthenics, and inspiratory muscle training)
A cardiac rehabilitation program for 3 days/week (day after day) for 12 weeks(including aerobic, and resisted exercise, with educational sessions, and counseling) only